Exosome levels in human body fluids: A tumor marker by themselves?

European Journal of Pharmaceutical Sciences

Volumn 96, Issue , 2017, Pages 93-98

  Cappello, Francesco ^a,b   Logozzi, Mariantonia ^c   Campanella, Claudia ^a,b   Bavisotto, Celeste Caruso ^a,b   Marcilla, Antonio ^d   Properzi, Francesca ^c   Fais, Stefano ^c  

^a UNIVERSITY OF PALERMO   (Italy)

^b Euro Mediterranean Institute of Science and Technology   (Italy)

^c ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^d UNIVERSITY OF VALENCIA   (Spain)

Author keywords

Biomarkers; Body fluids; Early diagnosis; Exosomes; Extracellular vesicles; Follow up; Prostate cancer

Indexed keywords

CAVEOLIN; IMATINIB; PROSTATE SPECIFIC ANTIGEN; PROTON PUMP INHIBITOR; SURVIVIN; TUMOR MARKER;

ARTICLE; BODY FLUID; BREAST CANCER; CANCER PATIENT; CANCER PROGNOSIS; CANCER SCREENING; COLON CANCER; COLORECTAL CANCER; DIAGNOSTIC TEST; EARLY CANCER DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; EXOSOME; FOLLOW UP; GASTROINTESTINAL STROMAL TUMOR; HUMAN; MELANOMA; MULTIVESICULAR BODY; NEOPLASM; OVERALL SURVIVAL; PANCREAS CANCER; PLASMA; PRIORITY JOURNAL; PROSTATE CANCER; TUMOR GROWTH; TUMOR RECURRENCE; URINE; METABOLISM; PATHOLOGY;

BIOMARKERS, TUMOR; BODY FLUIDS; EXOSOMES; HUMANS; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS;

EID: 84987926205     PISSN: 09280987     EISSN: 18790720     Source Type: Journal    
DOI: 10.1016/j.ejps.2016.09.010     Document Type: Article

References (58)

1. Alegre, E., Zubiri, L., Perez-Gracia, J.L., González-Cao, M., Soria, L., Martín-Algarra, S., González, A., Circulating melanoma exosomes as diagnostic and prognosis biomarkers. Clin. Chim. Acta 454 (2016), 28–32.
2. Andriole, G.L., The impact of prostate cancer and hormonal therapy on bone. Rev. Urol. 11 (2009), 185–189 Fall.
3. Brawley, O.W., Prostate cancer screening: what we know, don't know, and believe. Ann. Intern. Med. 157 (2012), 135–136.
4. Caivano, A., Laurenzana, I., De Luca, L., La Rocca, L., Simeon, V., Trino, S., D'Auria, F., Traficante, A., Maietti, M., Izzo, T., D'Arena, G., Mansueto, G., Pietrantuono, G., Laurenti, L., Musto, P., Del Vecchio, L., High serum levels of extracellular vesicles expressing malignancy-related markers are released in patients with various types of hematological neoplastic disorders. Tumour Biol. 36 (2015), 9739–9752.
5. Campanella, C., Bucchieri, F., Merendino, A.M., Fucarino, A., Burgio, G., Corona, D.F., Barbieri, G., David, S., Farina, F., Zummo, G., Conway de Macario, E., Macario, A.J.L., Cappello, F., The odyssey of Hsp60 from tumor cells to other destinations includes plasma membrane-associated stages and Golgi and exosomal protein-trafficking modalities. PLoS One, 7, 2012, e42008.
6. Campanella, C., Rappa, F., Sciumè, C., Marino Gammazza, A., Barone, R., Bucchieri, F., David, S., Curcurù, G., Caruso Bavisotto, C., Pitruzzella, A., Geraci, G., Modica, G., Farina, F., Zummo, G., Fais, S., Conway de Macario, E., Macario, A.J.L., Cappello, F., Heat shock protein 60 levels in tissue and circulating exosomes in human large bowel cancer before and after ablative surgery. Cancer 121 (2015), 3230–3239.
7. Cantaluppi, V., Gatti, S., Medica, D., Figliolini, F., Bruno, S., Deregibus, M.C., Sordi, A., Biancone, L., Tetta, C., Camussi, G., Microvesicles derived from endothelial progenitor cells protect the kidney from ischemia–reperfusion injury by microRNA-dependent reprogramming of resident renal cells. Kidney Int. 82 (2012), 412–427.
8. Catalona, W.J., Smith, D.S., Ratliff, T.L., Dodds, K.M., Coplen, D.E., Yuan, J.J., Petros, J.A., Andriole, G.L., Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. N. Engl. J. Med. 324 (1991), 1156–1161.
9. Chevillet, J.R., Kang, Q., Ruf, I.K., Briggs, H.A., Vojtech, L.N., Hughes, S.M., Cheng, H.H., Arroyo, J.D., Meredith, E.K., Gallichotte, E.N., et al. Quantitative and stoichiometric analysis of the microRNA content of exosomes. Proc. Natl. Acad. Sci. U. S. A. 111 (2014), 14888–14893.
10. Colombo, E., Borgiani, B., Verderio, C., Furlan, R., Microvesicles: novel biomarkers for neurological disorders. Front. Physiol., 3, 2012, 63.
11. Cooper, J.M., Wiklander, P.B., Nordin, J.Z., Al-Shawi, R., Wood, M.J., Vithlani, M., Schapira, A.H., Simons, J.P., El-Andaloussi, S., Alvarez-Erviti, L., Systemic exosomal siRNA delivery reduced alpha-synuclein aggregates in brains of transgenic mice. Mov. Disord. 29 (2014), 1476–1485.
12. Corbin, I.R., Zheng, G., Mimicking nature's nanocarrier: synthetic low-density lipoprotein-like nanoparticles for cancer-drug delivery. Nanomedicine (London) 2 (2007), 375–380.
13. Cossetti, C., Lugini, L., Astrologo, L., Saggio, I., Fais, S., Spadafora, C., Soma-to-germline transmission of RNA in mice xenografted with human tumour cells: possible transport by exosomes. PLoS One, 2014, 9e101629.
14. Dai, S., Wei, D., Wu, Z., Zhou, X., Wei, X., Huang, H., Li, G., Phase I clinical trial of autologous ascites-derived exosomes combined with GM-CSF for colorectal cancer. Mol. Ther. 16 (2008), 782–790.
15. Duijvesz, D., Versluis, C.Y., van der Fels, C.A., Vredenbregt-van den Berg, M.S., Leivo, J., Peltola, M.T., Bangma, C.H., Pettersson, K.S., Jenster, G., Immuno-based detection of extracellular vesicles in urine as diagnostic marker for prostate cancer. Int. J. Cancer 137 (2015), 2869–2878.
16. El Andaloussi, S., Mager, I., Breakefield, X.O., Wood, M.J., Extracellular vesicles: biology and emerging therapeutic opportunities. Nat. Rev. Drug Discov. 12 (2013), 347–357.
17. Escudier, B., Dorval, T., Chaput, N., Andre, F., Caby, M.P., Novault, S., Flament, C., Leboulaire, C., Borg, C., Amigorena, S., et al. Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of the first phase I clinical trial. J. Transl. Med., 3, 2005, 10.
18. Etzioni, R., Feuer, E., Studies of prostate-cancer mortality: caution advised. Lancet Oncol. 9 (2008), 407–409.
19. Fais, S., Logozzi, M., Lugini, L., Federici, C., Azzarito, T., Zarovni, N., Chiesi, A., Exosomes: the ideal nanovectors for biodelivery. Biol. Chem. 394 (2013), 1–15.
20. Fais, S., O'Driscoll, L., Borras, F.E., Buzas, E., Camussi, G., Cappello, F., et al. Evidence-based clinical use of nanoscale extracellular vesicles in nanomedicine. ACS Nano, 2016 Mar 15. [Epub ahead of print].
21. Fang, R.H., Hu, C.M., Luk, B.T., Gao, W., Copp, J.A., Tai, Y., O'Connor, D.E., Zhang, L., Cancer cell membrane-coated nanoparticles for anticancer vaccination and drug delivery. Nano Lett. 14 (2014), 2181–2188.
22. Federici, C., Petrucci, F., Caimi, S., Cesolini, A., Logozzi, M., Borghi, M., D'Ilio, S., Lugini, L., Violante, N., Azzarito, T., Majorani, C., Brambilla, D., Fais, S., Exosome release and low pH belong to a framework of resistance of human melanoma cells to cisplatin. PLoS One, 9, 2014, e88193.
23. Gamez-Valero, A., Lozano-Ramos, S.I., Bancu, I., Lauzurica-Valdemoros, R., Borras, F.E., Urinary extracellular vesicles as source of biomarkers in kidney diseases. Front. Immunol., 6, 2015, 6.
24. Hoffman, R.M., Clinical practice. Screening for prostate cancer. N. Engl. J. Med. 365 (2011), 2013–2019.
25. Hoshino, A., Costa-Silva, B., Shen, T.L., Rodrigues, G., Hashimoto, A., Tesic Mark, M., et al. Tumour exosome integrins determine organotropic metastasis. Nature 527 (2015), 329–335.
26. Huber, V., Fais, S., Iero, M., Lugini, L., Canese, P., Squarcina, P., et al. Human colorectal cancer cells induce T-cell death through release of proapoptotic microvesicles: role in immune escape. Gastroenterology 128 (2005), 1796–1804.
27. Iero, M., Valenti, R., Huber, V., Filipazzi, P., Parmiani, G., Fais, S., Rivoltini, L., Tumour-released exosomes and their implications in cancer immunity. Cell Death Differ. 15 (2008), 80–88.
28. Khan, S., Jutzy, J.M.S., Valenzuela, M.M.A., Turay, D., Aspe, J.R., Ashok, A., Mirshahidi, S., Mercola, D., Lilly, M.B., Wall, N.R., Plasma-derived exosomal survivin, a plausible biomarker for early detection of prostate cancer. PLoS One, 7, 2012, e46737.
29. Kooijmans, S.A.A., Vader, P., van Dommelen, S.M., van Solinge, W.W., Schiffelers, R.M., Exosome mimetics: a novel class of drug delivery systems. Int. J. Nanomedicine 7 (2012), 1525–1541.
30. Lammers, T., Aime, S., Hennink, W.E., Storm, G., Kiessling, F., Theranostic nanomedicine. Acc. Chem. Res. 44 (2011), 1029–1038.
31. Lener, T., Gimona, M., Aigner, L., Börger, V., Buzas, E., Camussi, G., Chaput, N., et al. Applying extracellular vesicles based therapeutics in clinical trials - an ISEV position paper. J. Extracell. Vesicles, 4, 2015, 30087.
32. Lo Cicero, A., Stahl, P.D., Raposo, G., Extracellular vesicles shuffling intercellular messages: for good or for bad. Curr. Opin. Cell Biol. 35 (2015), 69–77.
33. Logozzi, M., De Milito, A., Lugini, L., Borghi, M., Calabro, L., Spada, M., Perdicchio, M., Marino, M.L., Federici, C., Iessi, E., et al. High levels of exosomes expressing CD63 and caveolin-1 in plasma of melanoma patients. PLoS One, 4, 2009, e5219.
34. Lowry, M.C., Gallagher, W.M., O'Driscoll, L., The role of exosomes in breast cancer. Clin. Chem. 61 (2015), 1457–1465.
35. Ludwig, A.K., Giebel, B., Exosomes: small vesicles participating in intercellular communication. Int. J. Biochem. Cell Biol. 44 (2012), 11–15.
36. Lugini, L., Valtieri, M., Federici, C., Cecchetti, S., Meschini, S., Condello, M., Signore, M., Fais, S., Exosomes from human colorectal cancer induce a tumor-like behavior in colonic mesenchymal stromal cells. Oncotarget, 2016, 10.18632/oncotarget.10574 Jul 13.
37. Melo, S.A., Luecke, L.B., Kahlert, C., Fernandez, A.F., Gammon, S.T., Kaye, J., et al. Glypican-1 identifies cancer exosomes and detects early pancreatic cancer. Nature 523 (2015), 177–182.
38. Mitchell, P.J., Welton, J., Staffurth, J., Court, J., Mason, M.D., Tabi, Z., Clayton, A., Can urinary exosomes act as treatment response markers in prostate cancer?. J. Transl. Med., 7, 2009, 4.
39. Mizutani, K., Terazawa, R., Kameyama, K., Kato, T., Horie, K., Tsuchiya, T., Seike, K., Ehara, H., Fujita, Y., Kawakami, K., Ito, M., Deguchi, T., Isolation of prostate cancer-related exosomes. Anticancer Res. 34 (2014), 3419–3423.
40. Mutschelknaus, L., Peters, C., Winkler, K., Yentrapalli, R., Heider, T., Atkinson, M.J., Moertl, S., Exosomes derived from squamous head and neck cancer promote cell survival after ionizing radiation. PLoS One, 11, 2016, e0152213.
41. Nawaz, M., Camussi, G., Valadi, H., Nazarenko, I., Ekström, K., Wang, X., Principe, S., Shah, N., Ashraf, N.M., Fatima, F., Neder, L., Kislinger, T., The emerging role of extracellular vesicles as biomarkers for urogenital cancers. Nat. Rev. Urol. 11 (2014), 688–701.
42. Nyalwidhe, J.O., Betesh, L.R., Powers, T.W., Jones, E.E., White, K.Y., Burch, T.C., Brooks, J., Watson, M.T., Lance, R.S., Troyer, D.A., Semmes, O.J., Mehta, A., Drake, R.R., Increased bisecting N-acetylglucosamine and decreased branched chain glycans of N-linked glycoproteins in expressed prostatic secretions associated with prostate cancer progression. Proteomics Clin. Appl. 7 (2013), 677–689.
43. Ogorevc, E., Kralj-Iglic, V., Veranic, P., The role of extracellular vesicles in phenotypic cancer transformation. Radiol. Oncol. 47 (2013), 197–205.
44. Parolini, I., Federici, C., Raggi, C., Lugini, L., Palleschi, S., De Milito, A., Coscia, C., et al. Microenvironmental pH is a key factor for exosome traffic in tumor cells. J. Biol. Chem. 284 (2009), 34211–34222.
45. Peinado, H., Aleckovic, M., Lavotshkin, S., Matei, I., Costa-Silva, B., Moreno-Bueno, G., Hergueta-Redondo, M., Williams, C., Garcia-Santos, G., Ghajar, C., et al. Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. Nat. Med. 18 (2012), 883–891.
46. Pocsfalvi, G., Raj, D.A., Fiume, I., Vilasi, A., Trepiccione, F., Capasso, G., Urinary extracellular vesicles as reservoirs of altered proteins during the pathogenesis of polycystic kidney disease. Proteomics Clin. Appl. 9 (2015), 552–567.
47. Properzi, F., Logozzi, M., Fais, S., Exosomes: the future of biomarkers in medicine. Biomark. Med 7 (2013), 769–778.
48. Quesenberry, P.J., Aliotta, J., Deregibus, M.C., Camussi, G., Role of extracellular RNA-carrying vesicles in cell differentiation and reprogramming. Stem Cell Res. Ther., 6, 2015, 153.
49. Schröder, F.H., PSA screening–a review of recent studies. Eur. J. Cancer 45 (2009), 402–404.
50. Sheridan, C., Exosome cancer diagnostic reaches market. Nat. Biotechnol. 34 (2016), 359–360.
51. Silva, J., Garcia, V., Rodriguez, M., Compte, M., Cisneros, E., Veguillas, P., et al. Analysis of exosome release and its prognostic value in human colorectal cancer. Genes Chromosom. Cancer 51 (2012), 409–418.
52. Steuber, T., O'Brien, M.F., Lilja, H., Serum markers for prostate cancer: a rational approach to the literature. Eur. Urol. 54 (2008), 31–40.
53. Stoorvogel, W., Kleijmeer, M.J., Geuze, H.J., Raposo, G., The biogenesis and functions of exosomes. Traffic, 3, 2002, 32-30.
54. Sturgeon, C.M., Duffy, M.J., Stenman, U.H., Lilja, H., Brünner, N., Chan, D.W., Babaian, R., et al. National Academy of Clinical Biochemistry. National Academy of Clinical Biochemistry laboratory medicine practice guidelines for use of tumor markers in testicular, prostate, colorectal, breast, and ovarian cancers. Clin. Chem. 54 (2008), e11–e79.
55. Torre, L.A., Bray, F., Siegel, R.L., Ferlay, J., Lortet-Tieulent, J., Jemal, A., Global cancer statistics, 2012. CA Cancer J. Clin. 65 (2015), 87–108.
56. Vickers, A.J., Thompson, I.M., Klein, E., Carroll, P.R., Scardino, P.T., A commentary on PSA velocity and doubling time for clinical decisions in prostate cancer. Urology 83 (2014), 592–596.
57. Yáñez-Mó, M., Siljander, P.R., Andreu, Z., Zavec, A.B., Borràs, F.E., Buzas, E.I., et al. Biological properties of extracellular vesicles and their physiological functions. J. Extracell. Vesicles, 4, 2015, 27066.
58. Zocco, D., Ferruzzi, P., Cappello, F., Kuo, W.P., Fais, S., Extracellular vesicles as shuttles of tumor biomarkers and anti-tumor drugs. Front. Oncol., 4, 2014, 267.